University of Louisville

ThinkIR: The University of Louisville's Institutional Repository
Electronic Theses and Dissertations
5-2017

Exploring a novel NF-ĸBNF- B- inhibiting nanoparticle for periodontitis
therapy.
Kameswara Satya Srikanth Upadhyayula
University of Louisville

Follow this and additional works at: https://ir.library.louisville.edu/etd
Part of the Dentistry Commons, and the Immunology and Infectious Disease Commons

Recommended Citation
Upadhyayula, Kameswara Satya Srikanth, "Exploring a novel NF-ĸB- inhibiting nanoparticle for
periodontitis therapy." (2017). Electronic Theses and Dissertations. Paper 2638.
https://doi.org/10.18297/etd/2638

This Master's Thesis is brought to you for free and open access by ThinkIR: The University of Louisville's Institutional
Repository. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator
of ThinkIR: The University of Louisville's Institutional Repository. This title appears here courtesy of the author, who
has retained all other copyrights. For more information, please contact thinkir@louisville.edu.

EXPLORING A NOVEL NF-ĸB- INHIBITING NANOPARTICLE FOR
PERIODONTITIS THERAPY
By

Kameswara Satya Srikanth Upadhyayula

A Thesis
Submitted to the Faculty of the
School of Dentistry of the University of Louisville
In Partial Fulfillment of the Requirement for the Degree of

Master of Science in Oral Biology

Department of Oral Health and Rehabilitation
University of Louisville, School of Dentistry
Louisville, KY

May 2017

Copyright by Kameswara Satya Srikanth Upadhyayula in 2017
All Rights Reserved

EXPLORING A NOVEL NF-ĸB- INHIBITING NANOPARTICLE FOR
PERIODONTITIS THERAPY
By
Kameswara Satya Srikanth Upadhyayula
BDS
A Thesis approved on
April 18 2017
By the following Thesis Committee:
___________________________________
Dr. Shuang Liang (Mentor)
___________________________________
Dr. Douglas Darling (Committee member)
____________________________________
Dr. Huizhi Wang (Committee member)

ii

DEDICATION

This thesis is dedicated to
My parents- USR Murthy and SK Devi
Brother- Soma Upadhyayula
Shanti Pittampalli

iii

ACKNOWLEDGEMENTS
The completion of this project required lot of guidance and assistance from many
people and I am extremely fortunate to have excellent guidance and support from
a lot of people whose names may not all be enumerated. Their contributions are
sincerely appreciated and acknowledged.

First and foremost, I would like to thank God, for giving me the strength, knowledge
and wisdom.

I would like to express my sincere thanks and deepest appreciation to my mentor,
Dr. Shuang Liang for his excellent mentorship, patience and support. I am also
thankful to my Committee members Dr. Douglas Darling and Dr. Huizhi Wang for
their guidance and help for the improvement of the project. A special thanks to Dr.
Douglas Darling for his encouragement throughout my time in the Master’s
Program.

I am thankful to Dr. Xingyu Duan for teaching me new techniques in the lab in a
friendly manner. I would also like to thank Aislinn Leah Hays for sharing her
knowledge. Thanks to Wei Zou and Dr. Li for their support in the lab. A special
thanks to Dr. Lahari Koneru and Himabindu Gogineni for their help.

My sincere thanks to my parents and my brother for their support, encouragement
and love without whose support I would never have been able to realize my
potential. I would like to thank my friends Md. Toufeeq, Dushyanth, Pujitha, Ravi,
Vineetha, Naveen, Raj, Satish, Murali, Madhuri, Ankita, Swetha, Shilpa, Muddasir,
Sonali, Hima, Angeline, and Bilal. Very special thanks to Shanti Pittampalli without
whom this dissertation would not have been possible.

iv

ABSTRACT
EXPLORING A NOVEL NF-ĸB- INHIBITING NANOPARTICLE FOR
PERIODONTITIS THERAPY
Kameswara Satya Srikanth Upadhyayula
April 2017
Periodontitis is an infection-driven inflammatory disease characterized by gingival
inflammation and bone loss. The NF-ĸB signaling pathway is pivotal in
osteoclastogenesis and infection-induced pro-inflammatory responses. The use of
nanoparticles as a vehicle to deliver drug increases stability, loading capacity, and
facilitates transmembrane transportation. The hypothesis was that a novel
nanoparticle carrying therapeutic NBD inhibitory peptides (NBD-nanoparticles) will
inhibit measures of periodontal disease. In this project, we tested the nanoparticles
for their ability to directly inhibit osteoclastogenesis and inflammation as an original
strategy for periodontitis therapy. We also tested the capability of the nanoparticles
to inhibit gingival inflammation and alveolar bone loss in an animal model.
Methods: In vitro- In order to test the impact of NBD-nanoparticles on
osteoclastogenesis, RAW 264.7 cells were stimulated using RANKL and treated
with NBD-nanoparticles. Controls included treatment with empty nanoparticles and
no treatment. Seven days later, the cultures were fixed and stained with
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TRAP, an osteoclast marker, and the number of multinucleated TRAP positive
cells were counted.
In order to test the impact of NBD-nanoparticles on pro-inflammatory responses,
RAW or THP1 cells were stimulated with the periodontal pathogen P. gingivalis,
treated with NBD-nanoparticles or empty nanoparticle and tested for expression of
cytokines critical in periodontitis, such as IL-1β, IL-6, TNFα by ELISA. Differences
were evaluated by ANOVA.
In vivo - NBD-nanoparticles were tested in a murine ligature-induced periodontitis
model where mice received a ligation around the second molar, P. gingivalis
infection and microinjections of NBD-nanoparticles, empty nanoparticles, or PBS
in the gingiva. Gingival tissue was tested for mRNA expression of pro-inflammatory
cytokines by real-time PCR. Alveolar bone loss was determined by measuring the
CEJ-ABC distance. Bacterial culture from oral swabs confirmed bacterial
persistence. Differences were evaluated by ANOVA.
Results: NBD-nanoparticles inhibit osteoclastogenesis directly and P. gingivalisinduced pro-inflammatory cytokine production. NBD-nanoparticle application
inhibits the gingival expression of periodontitis-related cytokines and alveolar bone
loss in a murine ligature model.
Conclusions: NBD-nanoparticle is able to inhibit osteoclastogenesis directly and
pro-inflammatory cytokines production in vitro. This nanoparticle prevents gingival
inflammation and bone loss in a murine model for periodontitis.
Keywords:

NBD-nanoparticles,

NF-ĸB

pathway,

osteoclastogenesis, inflammation, alveolar bone loss
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CHAPTER 1: INTRODUCTION
Periodontitis, an inflammatory disease that results in a progressive loss of
tooth-supporting bone, effects over 47% of the American adult population ranging
from mild, moderate to severe forms of the disease (Eke et al., 2012). Destruction
of tissue is pathognomonic of the disease which leads to gingival recession or
periodontal pockets and the loss of alveolar bone. As a consequence of decreased
tissue support around the tooth structure, mobility and eventual loss of tooth
occurs.
Epidemiological studies estimate that the disease affects 70% of the US adults
aged 65 years or older (Papapanou, 2012). Globally, it affects 10-15% of the adult
population according to WHO (Petersen & Ogawa, 2005). Apart from being the
most common chronic infection among adults, the treatment also imposes a huge
economic burden globally (Loesche & Grossman, 2001). A study estimates that
the projected cost could be over 1 billion dollars if only 10% of the periodontitis
patients undergo periodontal therapy (Loesche & Grossman, 2001). Ironically, a
majority of the people suffering from the disease belong to low-income groups and
are unlikely to get the treatment done (Borrell & Crawford, 2012).
The interaction between the plaque and the host is considered the primary
etiological factor in the disease. The dental plaque contains a complex of multibacterial species that together form a biofilm. Plaque if not removed mechanically
on a regular basis, advances into a matured plaque, which consists of pathogenic
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bacteria leading to dysbiotic changes. Dysbiosis, a state of impaired microbiota, is
increasingly being acknowledged as a causative factor in many inflammatory
diseases. This altered host-microbe cross-talk is also implicated in Periodontitis,
the most common inflammatory disease of the oral cavity (Hajishengallis &
Lamont, 2014).
The periodontal disease, which is one of the main causes of tooth loss, was
once thought to be a localized infection (Ahn et al., 2012; Southerland et al., 2005).
However, it is now considered as a risk factor for some cardiovascular, respiratory,
endocrine, musculoskeletal, and reproductive system related abnormalities by
being a continuous source of infection (Arigbede et al., 2012; Yakob et al., 2012).

Periodontal disease and oral pathogens:
The oral cavity, which has a diverse ecosystem, is inhabited by a plethora
of bacteria which is estimated to be around 700 species. However, not all the
microorganisms are harmful as the disease is caused only by an increase in the
abundance of specific microbes (Suzuki et al., 2013). Among the bacteria,
Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, Tannerella
forsythia (formerly Bacteroides forsythus), Porphyromonas gingivalis, Prevotella
intermedia, Treponema denticola are important periodontal pathogens (Aruni et
al., 2015)
To explain the etiology of the biofilm-induced disease, many theories have
been put forth based on the role of microorganisms in the initiation and progression
of the disease. Specific microorganisms, non-specific plaque, specific plaque, red
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complex, key stone pathogen, poly microbial synergy and dysbiosis are a few
among them (Hajishengallis & Lamont, 2012). According to the red complex
concept, a group of three species is associated with the severe forms of disease
including

Porphyromonas

gingivalis, Treponema

denticola and Tannerella

forsythia (Socransky et al., 1998). Keystone pathogen theory postulates that the
low abundance keystone microorganisms can disrupt the tissue homeostasis
thereby causing tissue destruction (Hajishengallis et al., 2011). Porphyromonas
gingivalis, one of the red complex organisms and a keystone pathogen has gained
special attention partly because it is easy to culture and genetically manipulate
(Hajishengallis & Lamont, 2012).
Although the etiology of periodontal disease is attributed to pathogenic
microorganisms, the mere presence of periodontal pathogens does not cause
tissue destruction by itself (Graves, 2008). Instead, the microorganisms involved
in the pathogenesis of the disease act by modulating the host immune response
(Reynolds et al., 2015). In other words, the bone loss in periodontitis is not just
because of the invasion of the organism but a consequence of the proinflammatory cytokines produced by the host in response to the pathogenic
organism (Benedetto et al., 2013; Kato et al., 2014).

Periodontal disease and Inflammation:
Inflammation is a common physiological response to harmful stimuli such
as a microbial challenge in this context. Initially, the disease starts as an
inflammatory response affecting the gingiva, a condition known as gingivitis.
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Removal of the harmful stimuli, the supra and subgingival plaque, at this stage
leads to tissue homeostasis resulting in restoration of tissue health.
However, the unremoved plaque coupled with factors such as poor oral hygiene,
smoking, and other systemic conditions results in a shift from an acute stage to a
chronic inflammation. The inflammation is a consequence of host responses to the
persistent microbial encounter resulting from the unremoved plaque.

Pro-inflammatory cytokines or simply inflammatory cytokines have
repercussions on the periodontium as a result of tissue destruction and disease
progression. On the other hand, anti-inflammatory cytokines are associated with
the attenuation of disease. In general, the pro-inflammatory cytokines have a
destructive role while the anti-inflammatory cytokines have a protective role
(Garlet, 2010).

Pro-inflammatory cytokines such as IL1-, IL-6, TNF are considered to
be the pro-osteoclastogenic factors and contribute to the bone loss, along with
Receptor activator of nuclear factor kappa-B ligand (RANKL) (Benedetto et al.,
2013; Kato et al., 2014). These cytokines destroy the periodontal tissue and
result in the attachment loss of the gingiva causing either gingival recession or
excessive periodontal pockets (Graves & Cochran, 2003).
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Interleukins are a group of cytokines produced by leukocytes. Proinflammatory cytokines responsible for the pathogenesis of the disease are
explained briefly here.
IL-1:
Interleukin 1 is produced by activated mononuclear phagocytes and is produced
in response to bacterial antigens and their products (Beuscher et al., 1990). There
are two types of interleukin1; interluekin1, interleukin 1. Though the two
subtypes of interleukin 1 bind to the same receptor, they have distinct functions.
IL-1 is produced by blood monocytes, tissue macrophages, skin dendritic cells,
and brain microglia. The precursor of IL-1 is inactive and it is activated by
cleavage of caspase-1. The precursor is released in response to TLR, active
complement proteins, cytokines and IL-1 itself (Garlanda et al., 2013). Studies
have shown that IL-1, found in abundance in the crevicular fluid of gingiva, is a
potent inducer of bone destruction and cause tissue destruction in inflammatory
diseases including periodontitis (Hou et al., 1995; Hönig et al., 1989).
IL-6:
IL-6 is a pro-inflammatory cytokine, which has been found in the gingival crevicular
fluid of periodontal patients. It plays a key role in acute inflammation and induces
bone destruction (Graves, 2008). It is produced by B-lymphocytes, monocytes and
macrophages, keratinocytes, endothelial cells, and fibroblasts. IL-6 is released in
response to a stimulus such as bacteria or its products and other cytokines such
as IL-1 and TNFα (Irwin & Myrillas, 1998). The pro-inflammatory cytokine aids in
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the pathogenesis of the periodontal disease by acting as a bone resorbing factor
(Graves, 2008).

Cytokine Effect
IL-1β
TNF-α
IL-6

Bone resorption; pro-inflammatory; fever
Bone resorption; pro-inflammatory; fever;
synergistic with IL-1β
B-cell differentiation; antibody production;
osteoclast differentiation

Table 1. Cytokines effect in inflammatory conditions
Reused from A clinical guide to periodontology: Pathology of periodontal disease Hasan
& Palmer, British Dental Journal.
TNFα:
Tissue necrosis factor  is considered one of the most potent cytokines which
induces osteoclastogenesis in inflammatory conditions such as rheumatoid
arthritis, orthopedic implant loosening, periodontitis and other chronic inflammatory
osteolytic diseases (Garlet, 2010; Lam et al., 2000; Zhang et al., 2001). TNFα has
been confirmed to upregulate the other cytokines such as IL-1β and IL-6 and has
been found in abundance in the gingival crevicular fluid (Benedetto et al., 2013;
Garlet, 2010). TNFα acts in the progression of the periodontal disease by multiple
mechanisms such as expression of chemokines, inflammatory mediators, matrix
metalloproteinases, osteoclastogenesis, and apoptosis of matrix-producing cells
(Graves & Cochran, 2003).
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In summary, these pro-inflammatory cytokines break down the tissue causing
attachment loss and bone resorption.
Periodontal disease and bone loss:
Alveolar bone loss in periodontitis is the main factor including attachment loss,
which is responsible for tooth mobility or even loss of the tooth. Bone loss is caused
by the osteoclasts by bone resorption. On the other hand, osteoblasts are the cells
that help in the bone deposition. In fact, the action of both osteoblasts and
osteoclasts is necessary for normal development, remodeling and functioning of
an organism. In health, the osteoblastic and osteoclastic activity are in a balanced
state where the amount of bone resorption equals the amount of deposition
resulting in a healthy maintenance of bone (Hienz et al., 2015).
Osteoclastogenesis is the development of the bone resorbing cells, the
Osteoclasts. Osteoclasts are terminally differentiated large cells with multiple
nuclei and originate from mononuclear cells of the hematopoietic stem cell lineage
(Florencio-Silva et al., 2015). Their unique structure consists of a ruffled border
seen on the cell surface that helps in secretion of enzymes as well as uptake of
matrix components. A Clear zone is seen encircling the ruffled border and helps in
resorption (Teti et al., 1991). Vacuoles and vesicles help in secretion of enzymes,
digestion or transport of products within the cell (Holtrop & King, 1977).
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Figure 1: Tartrate resistant acid phosphatase positive (TRAP) Osteoclast
Arrow indicates the TRAP-positive cell: osteoclast.

The lysosomes contain large amounts of Tartrate-resistant acid phosphatase
(TRAP) and is a useful cytochemical marker (Ballanti et al., 1997). Excessive
osteoclastogenesis shifts the balance in favor of extensive bone loss as seen in

periodontitis.

NFκB Signaling pathway and Periodontal disease:
NF-ĸB (Nuclear factor kappa-light-chain-enhancer of activated B cells) signaling
pathway is critical in osteoclastogenesis and infection-induced pro-inﬂammatory
responses for being at the juncture of diverse signaling pathways (Abu-Amer,
2013; Lawrence, 2009). Blocking this pathway has become an attractive target in
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inflammatory diseases such as cancer and chronic inflammatory diseases and is
possible with Nemo Binding Domain (NBD) inhibitory peptide (Pan et al., 2011).
NF-ĸB consists of transcription factors which are pivotal in cellular growth and
development, regulating immune and inflammatory responses, and apoptosis
(Oeckinghaus & Ghosh, 2009). These factors are responsible for a number of
disease states such as atherosclerosis, heart disease, rheumatoid arthritis, cancer
and also Periodontitis (Nichols et al., 2001; Okamoto, 2006; Ross et al., 2001;
Valen et al., 2001; Gilmore et al., 2002).

The NF-ĸB protein family is divided into two subfamilies: the ‘’NF-ĸB’’ proteins and
‘’Rel’’ proteins. NF-ĸB proteins include p105, p100. The Rel subfamily includes cRel, RelB, RelA (aka p65). Rel proteins contain C-terminal transactivation domains
and can activate transcription. Long C- terminal domains with multiple copies of
Ankyrin repeats on the NF-ĸB subfamily of proteins make them inactive. These
proteins become short to get active by either limited proteolysis or arrested
translation (p105 to p50 and p100 to p52). This necessitates NF-ĸB subfamily to
form dimers with members of the Rel subfamily to activate transcription (Gilmore,
2006). The active form of NF-ĸB is thus a heterodimer consisting p65 and p50
subunits (Barnes & Karin, 1997).

As the NF-ĸB pathway is involved in many important cellular responses, its tight
regulation is justified. This is done by the interaction with the inhibitory proteins
IkB such as IkBα, IkB β, IkB γ, IkB ē which have different affinities for individual
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NF-ĸB dimers. As such, in most of the cells, NF-ĸB is present in an inactive form
in the cytoplasm along with IkB protein (Oeckinghaus & Ghosh, 2009). The NFĸB signaling is activated by a stimulus, bacteria/bacterial products in this
circumstance. The activation of NF-ĸB requires IKKα, IKKβ and the regulatory
protein NF-ĸB essential modifier IKK γ (or NEMO) which together constitute the
IKK complex (Hacker & Karin, 2006).

Figure 2: The NF-ĸB Protein family
Image showing the classification of mammalian NF-ĸB proteins.

The IKK complex phosphorylates IKB leading to ubiquitination and degradation.
NF-ĸB which is now free can translocate into the nucleus where it initiates
transcription (Oeckinghaus & Ghosh, 2009).

NF-ĸB activation can occur by two main pathways: Canonical or classical and noncanonical pathway. Recent studies show that the canonical and the non-canonical
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pathway are involved in innate immunity and adaptive immunity respectively
(Bonizzi & Karin, 2004).

Figure 3: Schematic depiction of the NF-κB pathway
The image depicts the mechanism of pro-inflammatory cytokine production and
osteoclastogenesis through activation of NF-ĸB.

The classical pathway can be stimulated by cytokines such as TNFα, interleukin 1
(IL-1), antigens and toll-like receptors (TLR4). It is mainly concerned with the
phosphorylation of IkB α and is dependent on IKKβ and IKK of the IKK complex,
resulting in the translocation of P65 protein heterodimers (Hayden & Ghosh, 2004;
Oeckinghaus et al., 2011).

11

Figure 4: Canonical (Left) and Non-canonical (Right) Pathways for the
Activation of
NF-κB
Figure reused with permission from Elsevier, Molecular cell, Two Pathways to NF-κB,
Pomerantz, Baltimore, October 2002.
On the other hand, the non-canonical pathway is induced by specific TNF
cytokines such as CD40 ligand, BAFF, and lymphotoxin-β except TNF (Bonizzi
& Karin, 2004; Oeckinghaus et al., 2011). It is dependent on IKKα-mediated
phosphorylation of P100- RelB, resulting in the formation of p52-RelB complexes
(Hayden & Ghosh, 2004).

The NF-ĸB pathway is important in pro-inflammatory signaling through the
production of cytokines, chemokines, and adhesion molecules (Lawrence, 2009).
In addition, NF-ĸB signaling transduction is pivotal in the downstream of
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RANK/RANKL pathway that leads to the development of osteoclasts (Yamaguchi
et al., 2012).

Periodontal pathogens, Porphyromonas gingivalis, and NFκB Signaling pathway:
Bacteria, bacterial products, and viruses are known to be the inducers of NF-ĸB,
which controls of transcription of around 150 target genes (Pahl, 1999). Among the
bacteria, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum,
Tannerella forsythia (formerly Bacteroides forsythus), Porphyromonas gingivalis,
Prevotella intermedia, Treponema denticola are important periodontal pathogens
and are known to be inducers of NF-ĸB (Kobayashi-Sakamoto et al., 2004; Walter
et al., 2004; Hasebe et al., 2004; Huang et al., 2004; Kim et al., 2004; Tanabe et
al., 2008; Tiranathanagul et al., 2004). Also, bacterial lipopolysaccharide (LPS)
has been shown to activate NF-ĸB signaling pathway (Sen & Baltimore, 1986).

Porphyromonas gingivalis is one of the major etiological organisms in the
pathogenesis of the periodontal disease that is also known to be an inducer of the
NF-ĸB (Groeger et al., 2017; Lamont & Jenkinson, 1998). Studies have shown that
LPS, one of the major constituent of the outer membrane of Porphyromonas
gingivalis, induces NF-ĸB (Ding et al., 2013). Also, studies have found that the
activation of NF-kB by P. gingivalis is through IkB kinase (IKK) complex (Carayol
et al., 2006). In addition, IKK , the regulatory protein is essential for the activation
of IKK complex in inflammation (May et al., 2000).
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LPS consists of three parts: lipid A, a core oligosaccharide, and an O side chain
(Raetz & Whitfield, 2002). Pathogen-associated molecular patterns (PAMPs) are
structures within a class of microbes that are recognized by pattern recognition
receptors (PRRs) present on the cells of innate immunity system (Mogensen,
2009). Lipid A of LPS is the main PAMP that is recognized by toll-like receptors, a
pattern recognition receptor (PRR). The LPS binds to toll-like receptors, mainly
TLR4 and upregulates the expression of nuclear factor-κB (NF-κB) (Wang et al.,
2000). Activation of NF-ĸB signaling pathway by Porphyromonas gingivalis leads
to the production of pro-inflammatory cytokines particularly interleukin-1β (IL-1β),
tumor necrosis factor-α (TNF-α) and IL-6 and osteoclastogenesis (Choi et al.,
2005) (Diya et al., 2008).

RANKL/RANK/OPG Pathway, NF-ĸB, and Osteoclastogenesis:
Many factors such as macrophage colony- stimulating factor (M-CSF), Receptor
activator of nuclear factor kappa-B ligand (RANKL) influence the formation of
osteoclasts the RANKL/RANK/OPG Pathway which is upstream of the NF-ĸB
signaling cascade.
NF-ĸB pathway is downstream of RANKL/RANK pathway and it is now established
that this pathway is critical and essential for osteoclastogenesis (Boyce, 2013).
RANKL, a member of TNF family, is a homotrimeric transmembrane protein
secreted by osteoblasts and stromal cells (Nelson et al., 2012). It is expressed in
bone and bone marrow, lymph nodes, thymus, spleen, mammary glands and the
brain (Liu & Zhang, 2015).
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Figure 5: The RANKL/RANK/OPG pathway for normal osteoclastogenesis.
Picture reused with permission from Dr. Brendan F Boyce, Biology of RANK, RANKL, and
Osteoprotegerin, Arthritis Research & Therapy2007

In Rheumatoid arthritis, RANKL is highly expressed and appears to be responsible
for the destruction of tissue at the joint (Geusens, 2012). Binding of RANKL to its
receptor RANK on osteoclast precursors leads to the formation of osteoclasts
(Khosla, 2001). To counteract the production of osteoclasts, a factor called
osteoprotegerin (OPG) is produced which binds to RANKL, thus acting as a decoy
receptor and inhibiting the osteoclastogenesis.
Receptor activator of NF-κB (RANK) is a member of tumor necrosis factor receptor
(TNFR) family and a type 1 homotrimeric transmembrane protein present in normal
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cells, mammary glands and in some cancer cells (Boyce & Xing, 2007). RANKL
binds to its receptor RANK resulting in osteoclastogenesis via activation of NF-ĸB.
RANKL/RANK/OPG axis is hence considered the central controller of the
osteoclastogenesis and function (Florencio-Silva et al., 2015; Kobayashi,
Udagawa, & Takahashi, 2009).

NF-ĸB pathway and Pro-inflammatory cytokines:
A coordinate regulation of the signaling pathways that regulate the expression of
pro-inflammatory and anti-inflammatory cytokines is necessary to maintain
health. This is because excessive production of pro-inflammatory cytokines
drives the tissue in favor of destruction. The significance of NF-ĸB pathway in the
expression of pro-inflammatory genes has been well-documented (Lawrence,
2009). These pro-inflammatory genes are responsible for the expression of
cytokines, chemokines, and adhesion molecules. Although cytokines produced
act independently, there is an associated crosstalk with other cytokines. NFκB
signaling pathway exhibits a broad control over the network and cascade of
cytokines by regulating the genes involved in the production of cytokines.
As previously mentioned, current evidence suggests that the pro-inflammatory
cytokines such as IL1-, IL-6, TNF contribute to the tissue destruction and bone
loss in periodontal disease (Benedetto et al., 2013; Kato et al., 2014; Graves &
Cochran, 2003). Furthermore, the periodontal pathogens Actinomycetes
actinomycetemcomitans and P. gingivalis have been shown to induce the
production of IL-1β, TNF-α, IL-6 through NFκB pathway (Kayal, 2013). NF-ĸB
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pathway is critical in the expression of cytokine genes involved in the
pathogenesis of periodontitis: IL-1 , IL-6, and TNF (Cogswell et al., 1994)
(Libermann & Baltimore, 1990; Liu et al., 2000). Hence, the NF-ĸB pathway
which includes both the canonical and the non-canonical pathway can be
described as the “mastermind” in the regulation of these pro-inflammatory
cytokines which are critical in the pathogenesis of periodontal disease.

NBD-nanoparticles:
Many authors have described this labyrinthine pathway as a “holy grail” of targeting
the pathway for therapeutic purposes (Firestein, 2004; Lawrence, 2009). One of
the approaches is to block the pathway with the help of an NBD peptide. The
NEMO binding domain (NBD) peptide is shown to effectively block the association
of NEMO with IKK complex thereby inhibiting NF-ĸB activation. This peptide
targets only the inflammation induced NF-ĸB activity, while sparing the protective
functions of basal NF-ĸB activity displaying fewer undesired side effects (Strickland
& Ghosh, 2006). Also, the traditional lipid bilayer system is ineffective in drug
delivery as the peptides are subjected to rapid protease degradation and limited
bioavailability due to their inability to pass through the cell membrane. The peptide
is incorporated into the outer lipid monolayer of the stable perfluorocarbon
nanoparticle system for effective drug delivery that ensures inhibition of NF-ĸB but
not complete suppression (Pan et al., 2011b).
The use of nanoparticles increases stability, loading capacity, and facilitates
transmembrane transportation of the drug. The efficacy of the NBD-nanoparticles
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in inhibiting bone loss in relation to periodontitis has not been tested to date. The
current treatment procedures for periodontitis are expensive, unaffordable by
those who require the treatment the most and require long-term maintenance by
the patients to be effective. The NBD-nanoparticles may prove to be a novel
therapeutic drug treating the disease more effectively, thus reducing the severity
of the disease.
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HYPOTHESIS
We hypothesized that the NBD-nanoparticles can lead directly to inhibition of
osteoclastogenesis and pro-inﬂammatory cytokines production in vitro. We also
hypothesized that this nanoparticle inhibits gingival inflammation and prevents
bone loss in a murine model for periodontitis.
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CHAPTER 2: MATERIALS AND METHODS
In vitro experiments:
Osteoclastogenesis:
RAW 264.7 cells (ATCC CLR-2278) were cultured (103 cells) in a 96 well plate in
α-MEM supplemented with 10% FBS and 100ng/ml murine soluble RANKL
(sRANKL) (Peprotech®). Nanoparticles of different dosages were added into the
cell culture (120, 600, 1200 and 2400 pM). Five days later, the cells were stained
for the enzyme tartrate-resistant acid phosphatase (TRAP) using the Leukocyte
Acid Phosphatase TRAP Kit (Sigma-Aldrich®). The number of multinucleated
TRAP-positive cells were counted which represent the multinucleated osteoclasts.
(Jacome-Galarza et al., 2013). NBD-nanoparticles and nanoparticles were
obtained from Washington University at St. Louis in collaboration with the
laboratories of Dr. Samuel A. Wickline and Dr. Hua Pan.

Pro-inflammatory cytokines expression:
The RAW 264.7 cells (ATCC CLR-2278) and THP 1 cells (Invivogen) were
separately stimulated with P. gingivalis 33277 (ATCC®) at MOI of 10:1 overnight.
Cells were treated with different dosages of nanoparticles (120, 600, 1200 and
2400 pM) along with P. gingivalis 33277 (ATCC®). The culture supernatant was
harvested after incubating overnight. The cytokine expression of IL-1β, IL-6, and
TNFα was measured by enzyme linked immunosorbent assay (ELISA).
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In vivo Experiments:
Murine ligature induced periodontitis model:
Mice received a ligature around the second molar, placed in the gingival sulcus.
(Abe & Hajishengallis, 2013). The ligature-induced periodontitis model is a
preferred method as it drastically reduces the time to develop periodontitis and by
exaggerating inflammation and bone loss (Molon et al., 2014; Oz & Puleo, 2011).

Figure 6: illustration of Steps involved in the ligation procedure
Picture reused with permission from Journal of Immunological Methods, Abe &
Hajishengallis, (2013). Optimization of the ligature-induced periodontitis model in mice.

A) 5–0 silk suture was passed in between the second molar and third molar using Dumont
forceps. (B) Suture was passed through between first molar and second molar using
Dumont forceps. (C) Suture was looped around the second molar (taking care to remove
the slack) using suture-tying forceps. (D) Suture was tied firmly using a triple-knot and
excess suture was cut using spring scissors.
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The mice were infected with 1 x 109 colony-forming units of P. gingivalis (3327;
American Type Culture) or 2% carboxymethylcellulose vehicle as a control every
other day for 3 times. Immediately after the ligation, micro-injections of 10μl of 1.2
nM NBD-Nanoparticles, nanoparticles or phosphate buffer solution (PBS) was
given in the palatal gingiva between first and second molars on day 1.

Numbers indicate Days

Pg Infection 1,3,5

1

3

5

8

LIGATION

Figure 7. Schematic depiction of the protocol for periodontitis induction in
vivo.
On the first, third and fifth day of ligation, microinjections of NBD- nanoparticles,
nanoparticles or phosphate buffer solution (PBS) was given in the palatal gingiva between
first and second molars. Additionally, they were infected with P. gingivalis on days 1, 3,
and 5. Seven days later the mice were harvested. Numbers indicate Days.
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Gingiva harvest and quantification of cytokines:
After seven days of ligation, the mice were sacrificed and the gingival tissue was
harvested.

Incisors

①

④③ ② ② ③④

Left molars

①

Figure 8: Illustration of the steps involved in the harvest of gingiva.
Incision ①, ②, ③ were made first. The red triangle part of the gingiva was grasped and
the lingual part of gingiva was pulled. Then, incision ④ was made and the black part of
the gingiva grasped and the buccal part of the gingiva pulled.

RNA was isolated using RNeasy kit (Qiagen). RNA was reversed-transcribed and
mRNA expression of cytokines - IL-1β, IL-6, TNFα, and RANKL was determined
by qualitative real-time PCR.
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Jaw harvest and Morphometrical analysis:
The skulls were subjected to boiling at 15psi for 10 minutes. After defleshing, the
maxillae were separated from the skulls. Maxillae were cleaned with gentle
brushing followed by bleaching overnight. Later, they were stained with 0.5% eosin
and 1% methylene blue (Abe & Hajishengallis, 2013). Alveolar bone heights were
assessed using a 40 X objective under a Nikon SMZ800 microscope (Nikon
Instruments Inc., NY, USA).

Figure 9: Picture of mice maxillary teeth showing the sites of measurement.
Arrows indicate the site of measurement. Measurements were taken at six different sitesthe mesial cusp, buccal groove and distal cusp of the first molar, the mesial cusp and distal
cusp of the 2nd molar, and buccal cusp of the third molar.

Bone heights were measured morphometrically and the images of the maxillae
were captured using a Nikon Digital Sight DS-U3 camera controller (Nikon
Instruments Inc.). Measurements were taken at six different sites- the mesial cusp,
buccal groove and distal cusp of the first molar, the mesial cusp and distal cusp of
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the 2nd molar, and buccal cusp of the third molar. The readings of CEJ-ABC
distance at each site were totaled for each mouse. Bone loss was calculated by
subtracting the six-site total CEJ-ABC distance for the ligated mice from the sixsite total CEJ-ABC distance of the unligated mice. Micro-CT was performed in the
Department of Radiology at University of Louisville.

Statistical analysis:
Data were evaluated by ANOVA (InStat v3.06 program, GraphPad) and
differences were considered significant at the p < 0.05 level.

Human Subjects: No human subjects were used in the experiment.

Vertebrate Animals: C57BL6 mice were purchased from the Jackson laboratory.
All experimental procedures were performed in accordance with the guidelines of
the Institutional Animal Care and Use Committee of University of Louisville, IACUC
number: 15323.
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CHAPTER 3: RESULTS
The overall strategy of this research is to investigate the ability of NBDnanoparticles to directly inhibit osteoclastogenesis, and the pro-inflammatory
cytokine response to a bacterial stimulus using in vitro studies. Also, to investigate
the therapeutic ability of NBD-nanoparticles to inhibit pro-inflammatory cytokine
production in the gingiva and reduce alveolar bone loss in a murine ligature
induced periodontitis model.

1) NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis:
Bone loss in periodontitis is a result of an imbalance in the osteoblastic and
osteoclastic activity. Since the current evidence attributes the bone loss to
osteoclastogenesis through the NF-ĸB pathway that is downstream of
RANKL/RANK pathway, we first investigated whether the NBD-nanoparticle can
prevent the RANKL-induced osteoclastogenesis in vitro.

Since osteoclasts are derived from monocyte precursors, we used the RAW cell
line cells which are murine monocyte/macrophages. Furthermore, RAW cells are
the most extensively used cell line for decades to study the differentiation of
osteoclasts (Collin-Osdoby et al., 2003; Jacome-Galarza et al., 2013).
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In order to test the ability of NBD-nanoparticles to prevent RANKL-induced
osteoclastogenesis, we examined the cells through microscopy, and osteoclastic
cell formation was determined by the number of multinucleated TRAP positive
cells. Cells with three or more nuclei were considered to be osteoclasts. Controls
included treatment with empty nanoparticles and no treatment. Cells with no
stimulation (RANKL) were also used.

In the cells without RANKL-stimulation and with or without NBD nanoparticle
treatment, there were virtually no TRAP-positive cells indicating that RANKL is
required for differentiation into osteoclasts. As expected, the cells incubated with
RANKL stimulated the formation of a large number of TRAP positive cells. This
indicates a crucial role of RANKL in initiating the RANKL/RANK pathway towards
osteoclastogenesis. After we treated the RAW cells with NBD-nanoparticles, the
formation of TRAP positive cells was significantly reduced (Fig 10, 11), while the
empty nanoparticles without NBD did not inhibit osteoclastogenesis (Fig 10). We
further counted the number of osteoclasts in each well. Our results showed that
NBD- nanoparticle effectively inhibited the osteoclastogenesis.
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RANK
L

NP

NP-NBD

Figure 10. NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis:
RAW 264.7 cells were treated with RANKL and 2.4µM of NBD-nanoparticles (NBDNP) or Nanoparticles (NP). Untreated cells (RANKL) or empty Nanoparticle (NP)
treated cells were used as controls. The cells were cultured for 5 days and stained
with TRAP.
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Figure 11. NBD-nanoparticle inhibits RANKL-induced osteoclastogenesis.
RAW 264.7 cells were treated with RANKL and 2.4µM of NBD-nanoparticles (NBDNP). Untreated (RANKL only) and empty nanoparticle treated cells were used as
controls. The cells were cultured for 5 days and stained with TRAP. The
multinucleated TRAP positive cells were counted per well. * p<0.05
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2.

NBD-nanoparticle

inhibits

P.

gingivalis-induced

pro-inflammatory

cytokine production:
It has already been reported that the NF-ĸB pathway is critical in the infectioninduced pro-inflammatory cytokine production. Moreover, considering the role of
inflammatory cytokines in the destruction of tooth supporting tissue in periodontitis,
we wanted to examine if NBD-nanoparticles will inhibit infection- induced proinflammatory cytokine expression relevant to periodontitis- IL-1β, IL-6 and TNFα.

For measuring the expression of IL-1β, IL-6 and TNFα by ELISA, either RAW cells
or THP1 cells were incubated overnight and the supernatant was harvested. The
cells that did not stimulated with P. gingivalis showed nearly negligible amounts of
IL-1β, suggesting that there was no NF-ĸB activation in the absence of infection.
In contrast, a dose dependent significant decrease in the amount of IL-1β was
noted in the cells that received NBD-nanoparticle treatment. At a treatment dose
of 2.4 µM of NBD nanoparticles, the amount of IL-1β was almost equivalent to the
unstimulated cells. This data confirms that the NBD-nanoparticles effectively block
the production of IL-1β (Fig.12).

Furthermore, cells expressed IL-6 responding to P. gingivalis stimulation, while the
amount of IL-6 was significantly reduced in the NBD-nanoparticle-treated human
monocyte cells. A dose-dependent decrease was observed from 0.6 to 1.2 µM
NBD-nanoparticles (Fig.12). Similarly, in murine macrophage cells, a small amount
of IL-6 expression was observed in the unstimulated cells treated with the empty
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nanoparticle (Fig. 13). The amount of IL-6 after treatment with NBD-nanoparticles
decreased to the level of unstimulated cells confirming that the NBD-nanoparticle
is capable of inhibiting the IL-6 production in vitro (Fig. 13).
Next, we investigated the expression of TNFα in murine macrophage cell line for
testing the efficacy of NBD-nanoparticles. Data showed that the unstimulated cells
only produce tiny amount of TNFα. Not surprisingly, P. gingivalis stimulation
induced TNFα production. Our data indicate a dosage-dependent decrease in the
TNFα levels after treatment with NBD-nanoparticles in P. gingivalis-infected cells
(Fig.13). This suggests that the NBD-nanoparticle is effective in suppressing TNFα
production.

In summary, our results corroborate that the NBD-nanoparticles are able to inhibit
the infection-induced production of IL-1β, IL-6 and TNFα, which are important
cytokines in the pathogenesis of the periodontal disease.
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Figure 12. NBD-nanoparticle inhibits P. gingivalis-induced pro-inflammatory
cytokine production by human monocytes: THP1 cells were treated with
different dosages (0.6, 1.2, and 2.4µM) of NBD-nanoparticles (NBD) at the time of
P. gingivalis (Pg) infection (MOI 10:1). The cells without stimulation (NS) were
used as controls. The cells were cultured overnight and supernatant were tested
for production of (A) IL-1 and (B) IL-6. Data presented as mean ± SD (n = 3).
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Fig. 13. NBD-nanoparticle inhibits P. gingivalis-induced pro-inflammatory
cytokine production by RAW cells. RAW cells were treated with different
dosages of NBD-nanoparticles (NBD) at the time of P. gingivalis (Pg) infection
(MOI 10:1). The cells were cultured overnight and supernatant were tested for
production of (A) TNFα and (B) IL-6. * p<0.05，**：p<0.01

33

In vivo experiments:
The overall strategy of the in vivo experiments is to determine the ability of NBDnanoparticles to effectively control the inflammation and inhibit alveolar bone loss.
For this purpose, a murine ligature-induced Periodontitis model was used (Abe &
Hajishengallis, 2013).

3. NBD-nanoparticle treatment inhibits expression of periodontitis-related
cytokines:
We have established that the NBD-nanoparticle can inhibit inflammatory cytokine
production in vitro. In addition, literature provides evidence that the production of
pro-inflammatory cytokines via NF-ĸB activation as a host response to the
microbial attack leads to tissue destruction in periodontitis. So, we wanted to
investigate the NBD-nanoparticle’s ability to inhibit inflammation in vivo using a
murine ligature-induced periodontitis model.
C57/BL6 mice were ligated and received micro-injections of NBD-nanoparticles.
Additionally, the ligated mice were infected with P. gingivalis three times every
other day. Controls included
ligated mice treated with empty nanoparticles or no treatment. On day 8, the mice
gingivae were harvested and tested for expression of cytokines, including RANKL,
IL-1β, IL-6 and IL-17 by quantitative RT-PCR.

Our results demonstrated a high level of expression of RANKL, IL-1β and IL-6
except IL-17 in the untreated mice (Fig. 14). Furthermore, the empty nanoparticle
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treated mice had no significant difference in the expression levels from the
untreated mice, although IL-17 relative levels were increased after treatment with
empty nanoparticles. Nonetheless, literature suggests a controversial dual role of
IL-17 in protection and progression of inflammatory diseases (Miossec et al., 2009;
Yu et al., 2007). However, the NBD-nanoparticle seemed to have a consistent
suppressive effect on all the tested cytokines, which is indicated by the decreased
relative levels of expression.

These data show that NF-ĸB inhibition by the NBD nanoparticle results in a
decreased expression of cytokines – RANKL, IL-1β, IL-17 and IL-6 in the gingiva.
In addition, these results indicate that the NBD-nanoparticle is able to inhibit
inflammation in the gingival tissues in the murine periodontitis model.
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Figure 14. NBD-nanoparticle treatment inhibits expression of periodontitisrelated cytokines. Relative expression of pro-inflammatory cytokines in the
gingivae of mice treated with NBD-nanoparticle (NBD-NP), empty nanoparticles
(NP), or without treatment (UT). Quantitative real-time PCR (qPCR) was used to
determine gingival mRNA expression levels for the indicated molecules
(normalized against GAPDH mRNA levels). The gingivae used were excised from
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C57/BL6 mice. Results are shown as fold change relative to sham-ligated mice,
respectively. Each data point represents the mean ± SD of 5 separate expression
values, each value corresponding to qPCR analysis of an individual mouse.
Asterisks indicate statistically significant (p < 0.05) differences between NBDnanoparticle treated mice and other groups.
4. NBD-nanoparticle inhibits alveolar bone loss in a ligature model:
As we have demonstrated that the NBD-nanoparticle is capable of inhibiting the
formation of the bone resorbing cells (osteoclasts) in vitro, we were interested in
investigating if the nanoparticle can block the NF-ĸB activation-induced
osteoclastogenesis leading to less severe bone loss. Thus, to examine the ability
of NBD-nanoparticles to inhibit alveolar bone loss, a murine ligature-induced
periodontitis model is used as previously described. Microinjections of NBDnanoparticles, nanoparticles or PBS was done. In addition, they were infected with
P. gingivalis every other day for 3 times. Control mice had sham-ligature and
sham-infection. Seven days’ post ligation, the mice were euthanized and the skulls
were harvested. Measurement of CEJ- ABC distance was done morphometrically
with the help of microscopy (Fig.15) and Micro-CT scan (Fig. 16) at six different
sites.

Our results showed that there was no significant difference in the CEJ-ABC
distance in the non-ligated group. Conversely, the ligated mice treated with empty
nanoparticles or no treatment exhibited more CEJ-ABC distance. However, the
NBD-nanoparticle treated mice showed a lesser CEJ-ABC measurement.
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Subsequently, we determined the bone loss, which was obtained by subtracting
the total CEJ-ABC distance of ligated to that of unligated mice (Fig. 17). Our results
demonstrated that the bone loss was significantly reduced after treatment with the
NBD-nanoparticles when compared to that of sham mice.
These results indicate that the NBD-nanoparticles markedly reduced the bone loss
in a murine ligature induced periodontitis model. This observation supports our
hypothesis that the NBD-nanoparticles through inhibition of NF-ĸB pathway
prevents the osteoclastogenesis thus reducing the bone loss.
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Figure 15. NBD-nanoparticle inhibits alveolar bone loss in a ligature model:
C57Bl/6 mice were ligated around 2nd molar to induce bone loss. The mice were
treated with NBD-NP, empty NP, or left untreated. The mm distance from the
cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) was measured
at 6 most affected maxillary buccal sites and the readings were totaled for each
mouse. Pictures were captured using a Nikon Digital Sight DS-U3 camera
controller (Nikon Instruments Inc.)
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Figure 16. NBD-nanoparticle inhibits alveolar bone loss in a ligature model:
C57Bl/6 mice were ligated around 2nd molar to induce bone loss. The mice were
treated with NBD-NP, empty NP, or left untreated. The mm distance from the
cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) was measured
at 6 most affected maxillary buccal sites and the readings were totaled for each
mouse.

40

2.0
1.5

Bone Loss (mm)

CEJ-ABC (mm)

2.5

*

2.0
1.5

*

*

Untreated

NP

*

1.0
0.5
0.0

NP-NBD

1.0
0.5
0.0

Untreated

NP

NP-NBD Untreated

Non-Ligated

NP

NP-NBD

Ligated

Figure 17. NBD-nanoparticle inhibits alveolar bone loss in a ligature model.
C57Bl/6 mice were ligated around 2nd molar to induce bone loss. The mice were
treated with NBD-NP, empty NP, or left untreated. The mm distance from the
cemento-enamel junction (CEJ) to the alveolar bone crest (ABC) was measured
at 6 most affected maxillary buccal sites and the readings were totaled for each
mouse. The data are means ± SD (n = 7 for untreated ligated and non-ligated, 9
for NP ligated and non-ligated, 10 for NBD-NP ligated and non-ligated mice). The
CEJ-ABC reading of each mouse was represented by each dot. Bone loss was
calculated by subtracting the six-site total CEJ-ABC distance for the ligated mice
from the six-site total CEJ-ABC distance of the unligated mice. Asterisks indicate
statistically significant (p < 0.05) differences between NBD-NP treated and other
groups.
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CHAPTER 4: DISCUSSION
Periodontitis is characterized by both gingival inflammation and alveolar bone loss.
NF-ĸB signaling pathway is pivotal in osteoclastogenesis and infection-induced
pro-inﬂammatory responses for being at the crossroad of a variety of signaling
pathways. Porphyromonas gingivalis (P. gingivalis) is one of the most important
and widely investigated periodontal disease etiological pathogens. Reasons for a
being an extensively studied organism in periodontitis might range from being a
key stone pathogen, member of red complex, persistence of the species in
periodontal patients to easy culture methods and genetic manipulation. In addition,
inoculation of P. gingivalis in animals induces gingival inflammation and alveolar
bone loss. Because of their critical role in host immune responses, NF-ĸB must be
tightly regulated to avoid excessive or defective immune responses. Many authors
have described NF-ĸB as “holy grail”, “master switch”, “master regulator”, “center
piece” of inflammatory responses (Abu-Amer, 2013; Firestein, 2004; Lawrence,
2009). As the evidence shows NF-ĸB to be a key player in the inflammation, the
pathway has been a therapeutic target for many researchers.

A nanoparticle cargo carrier undergoing FDA-approved clinical trials has been
linked with therapeutic peptide, Nemo Binding Domain (NBD) inhibitory peptide,
which prevents NF-ĸB activation. A peptide-nanoparticle complex is formed and
inhibition of NF-ĸB signaling has been demonstrated. We hypothesized that
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the NBD-nanoparticles can lead to inhibition of osteoclastogenesis directly and
pro-inﬂammatory cytokines production in vitro. We also hypothesized that this
nanoparticle inhibits gingival inflammation and prevents bone loss in a murine
model for periodontitis.

A right balance between the bone forming osteoblasts and bone resorbing
osteoclasts is of utmost importance for the bone homeostasis and maintenance.
When the balance tips towards formation of excessive osteoclasts, it results in
bone resorption. Because periodontal disease is characterized by bone loss and
the NF-ĸB activation leads to formation of bone resorbing cells, we wanted to
establish the ability of the NBD-nanoparticles to prevent RANKL-induced
osteoclastogenesis. Our results demonstrated a decrease in the number of TRAPpositive cells after treatment with the NBD-nanoparticles confirming that the NBDnanoparticle is able to inhibit RANKL-induced osteoclastogenesis by blocking the
NF-ĸB pathway (Fig.11). Furthermore, we wanted to investigate the ability of this
nanoparticle to inhibit pro-inflammatory cytokine production. Since, periodontal
disease is a repercussion of chronic inflammation and the NF-ĸB pathway has a
central role in the production of cytokines especially those that are implicated in
periodontitis, we examined the expression of these cytokines- IL-1β, IL-6 and
TNFα (Fig. 12,13). Our data showed a marked reduction in the levels of cytokines
and suggested that the NBD-nanoparticles are effective in inhibiting the proinflammatory cytokine production by blocking the NF-ĸB.
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After establishing the action of NBD-nanoparticles in a set of in vitro experiments,
we studied the ability of these nanoparticles in vivo. For this purpose, we used a
murine ligature-induced periodontitis model and additionally infected them with P.
gingivalis to exacerbate the gingival inflammation. Our results were consistent with
the in vitro experiment data and demonstrated a decrease in the expression of
inflammatory cytokines important in the pathogenesis of the periodontal disease
(Fig. 14). Similarly, the NBD-nanoparticle treated group showed less CEJ-ABC
distance when compared to the untreated (Fig. 17). This data suggests that the
nanoparticles are effective in inhibiting gingival inflammation and alveolar bone
loss in a murine ligature-induced periodontitis model.

Normally, in response to an infection, the IKK complex is activated by the
binding of IKKγ to the IKKα and IKKβ subunits. This leads to the phosphorylation
of the IkB rendering the free NF-ĸB to translocate to the nucleus thus initiating
the expression of genes involved in the production of pro-inflammatory cytokines
and osteoclastogenesis. The nanoparticle cargo delivers the NBD inhibitory
peptide in to the cell and the peptide prevents the binding of IKKγ to the Nemo
binding domain, thus blocking the downstream pathway that leads to the
production of NF-ĸB. This results in the prevention of inflammation and bone
loss.

Future studies might be directed at testing the nanoparticles using the other
bacteria associated with the pathogenesis of the disease. Indeed, this study might
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provide data on differential expression of cytokines by different bacteria and also
the amount of suppression of the inflammation and bone loss by the nanoparticles.
Also, nanoparticles with another peptide as a control can be used to check if the
action is caused by the NBD nanoparticles. Characterization of the cell types that
are involved in cytokine production is another direction of future studies. As the
nanoparticle can be used as a drug delivery vehicle for other peptides, other
processes of the NFkB pathway can be blocked.

In summary, our experimental results have indicated that this novel peptidenanoparticle complex is effective to inhibit pro-inflammatory cytokine production,
and

RANKL-induced

osteoclastogenesis.

This

nanoparticle

inhibits

pro-

inflammatory cytokine expression in gingivae and prevents alveolar bone loss in a
murine model for periodontitis. This novel nanoparticle showed significant
therapeutic potential to cure periodontitis and other inflammatory diseases.
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